24 May 2017

The Manager Announcements Company Announcements Office ASX Limited

20 Bridge Street

SYDNEY NSW 2000

Announcement

Algae.tec's Managing Director Peter Hatfull and Operations Director Earl McConchie are currently in Uruguay meeting with the Board of Winter Garden Biosciences to finalise due diligence for the recently announced Collaboration and Licensing Agreement that expands Algae.tec into the medicinal marijuana industry.

Mr Hatfull will then travel to the United States to give presentations to the investment community to roadshow the Company for capital raising associated with the Collaboration and Licensing Agreeent.

A copy of his presentation to investors is hereby attached.

NATURAL HEALTH AND ENERGY A Renewable, Sustainable and Scalable Business Disclaimer

This presentation has been prepared by Algae.Tec Limited. This presentation contains a number of forward-looking statements that are subject to risks, contingencies and uncertainties. Such statements involved known and unknown risks and certain assumptions that may cause the actual results, performance or achievements of the Company to be materially different from the statements in this presentation.

Actual results could differ depending on factors including, but not limited to, the availability of resources, testing of the Company's technology on a commercial scale, timing and effects of regulatory actions, liquidity of the Company's shares and the Company's commercial partners.

2

Company Overview A global leader in diversified quality algae and medicinal cannabis products.

  • Algae.Tec is a specialist producer, focused on developing technology that captures waste carbon dioxide to produce commercial quantities of a range of plant derived products for use in the fuel, nutraceuticals, animal feed, aquaculture and medicinal sectors.

  • Algae.Tec has carried out in excess of six years of laboratory, bench-scale and pilot tests and product trials to-date; assessed competitive technologies; and has applied the development phase results to detailed engineering evaluations of commercial plant operations.

  • Algae.Tec's technology has demonstrated exceptional performance, providing step-change improvements in productivity, product yield, carbon dioxide sequestration, plant footprint requirements and substantial capital and operational cost savings versus agricultural crops and other competitive processes in the industry.

  • Algae.Tec's is uniquely positioned to develop, produce and supply nutraceuticals, animal feed, aquaculture and cannabinoids that enable and enhance the delivery and commercial success of those products

  • Algae.Tec is on the fast track to multiple cash flow streams

3

Algae.Tec Limited published this content on 24 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 May 2017 03:05:20 UTC.

Original documenthttp://algaetec.com.au/index.php/investors/asx-announcements?task=document.viewdoc&id=95

Public permalinkhttp://www.publicnow.com/view/2B2E09A4D9735C5558A10DBCF4C234514B894F07